Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD2936 |
| Trade Name | |
| Synonyms | AZD-2936|AZD 2936|Rilvegostomig |
| Drug Descriptions |
AZD2936 is a bispecific antibody that targets T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT) and PD-1 (PDCD1), which potentially leads to increased T-lymphocyte antitumor activity, tumor cell killing, and inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |
| DrugClasses | PD-L1/PD-1 antibody 132 TIGIT Antibody 20 |
| CAS Registry Number | NA |
| NCIT ID | C188211 |